These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 12531521)
1. Differences in the activation of the GFAP gene promoter by prion and viral infections. Titeux M; Galou M; Gomes FC; Dormont D; Neto VM; Paulin D Brain Res Mol Brain Res; 2002 Dec; 109(1-2):119-27. PubMed ID: 12531521 [TBL] [Abstract][Full Text] [Related]
2. Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-lacZ transgenes. Johnson WB; Ruppe MD; Rockenstein EM; Price J; Sarthy VP; Verderber LC; Mucke L Glia; 1995 Mar; 13(3):174-84. PubMed ID: 7782103 [TBL] [Abstract][Full Text] [Related]
3. Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene. Lee Y; Su M; Messing A; Brenner M Glia; 2006 May; 53(7):677-87. PubMed ID: 16482522 [TBL] [Abstract][Full Text] [Related]
4. Normal and pathological expression of GFAP promoter elements in transgenic mice. Galou M; Pournin S; Ensergueix D; Ridet JL; Tchélingérian JL; Lossouarn L; Privat A; Babinet C; Dupouey P Glia; 1994 Dec; 12(4):281-93. PubMed ID: 7890332 [TBL] [Abstract][Full Text] [Related]
5. AP-1 and the injury response of the GFAP gene. Brenner M; Messing A; Olsen ML J Neurosci Res; 2019 Feb; 97(2):149-161. PubMed ID: 30345544 [TBL] [Abstract][Full Text] [Related]
6. GFAP promoter directs astrocyte-specific expression in transgenic mice. Brenner M; Kisseberth WC; Su Y; Besnard F; Messing A J Neurosci; 1994 Mar; 14(3 Pt 1):1030-7. PubMed ID: 8120611 [TBL] [Abstract][Full Text] [Related]
7. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2. Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885 [TBL] [Abstract][Full Text] [Related]
8. Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. Mucke L; Oldstone MB; Morris JC; Nerenberg MI New Biol; 1991 May; 3(5):465-74. PubMed ID: 1883812 [TBL] [Abstract][Full Text] [Related]
9. GFAP promoter elements required for region-specific and astrocyte-specific expression. Lee Y; Messing A; Su M; Brenner M Glia; 2008 Apr; 56(5):481-93. PubMed ID: 18240313 [TBL] [Abstract][Full Text] [Related]
10. Abnormal activation of glial cells in the brains of prion protein-deficient mice ectopically expressing prion protein-like protein, PrPLP/Dpl. Atarashi R; Sakaguchi S; Shigematsu K; Arima K; Okimura N; Yamaguchi N; Li A; Kopacek J; Katamine S Mol Med; 2001 Dec; 7(12):803-9. PubMed ID: 11844868 [TBL] [Abstract][Full Text] [Related]
11. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance. Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771 [TBL] [Abstract][Full Text] [Related]
12. Dual transgenic reporter mice as a tool for monitoring expression of glial fibrillary acidic protein. Cho W; Hagemann TL; Johnson DA; Johnson JA; Messing A J Neurochem; 2009 Jul; 110(1):343-51. PubMed ID: 19457099 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of a glial fibrillary acidic protein-LacZ transgene in retinal astrocytes and Müller cells. Verderber L; Johnson W; Mucke L; Sarthy V Invest Ophthalmol Vis Sci; 1995 May; 36(6):1137-43. PubMed ID: 7730023 [TBL] [Abstract][Full Text] [Related]
14. Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements. de Leeuw B; Su M; ter Horst M; Iwata S; Rodijk M; Hoeben RC; Messing A; Smitt PS; Brenner M J Neurosci Res; 2006 Apr; 83(5):744-53. PubMed ID: 16496373 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of glial fibrillary acidic protein fragments and mu-calpain activation within the hippocampus of prion-infected mice. Gray BC; Skipp P; O'Connor VM; Perry VH Biochem Soc Trans; 2006 Feb; 34(Pt 1):51-4. PubMed ID: 16417481 [TBL] [Abstract][Full Text] [Related]
16. GFAP promoter drives Müller cell-specific expression in transgenic mice. Kuzmanovic M; Dudley VJ; Sarthy VP Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3606-13. PubMed ID: 12882814 [TBL] [Abstract][Full Text] [Related]
17. Glial fibrillary acidic protein transcription responses to transforming growth factor-beta1 and interleukin-1beta are mediated by a nuclear factor-1-like site in the near-upstream promoter. Krohn K; Rozovsky I; Wals P; Teter B; Anderson CP; Finch CE J Neurochem; 1999 Apr; 72(4):1353-61. PubMed ID: 10098836 [TBL] [Abstract][Full Text] [Related]
18. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions. Sousa Vde O; Romão L; Neto VM; Gomes FC Eur J Neurosci; 2004 Apr; 19(7):1721-30. PubMed ID: 15078546 [TBL] [Abstract][Full Text] [Related]
19. A 1.8kb GFAP-promoter fragment is active in specific regions of the embryonic CNS. Andrae J; Bongcam-Rudloff E; Hansson I; Lendahl U; Westermark B; Nistér M Mech Dev; 2001 Sep; 107(1-2):181-5. PubMed ID: 11520676 [TBL] [Abstract][Full Text] [Related]
20. Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter. Morimoto S; Cassell MD; Beltz TG; Johnson AK; Davisson RL; Sigmund CD Circ Res; 2001 Aug; 89(4):365-72. PubMed ID: 11509454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]